We’re currently inviting healthy post menopausal women to take part in a clinical study evaluating a potential new treatment for Vulvovaginal Atrophy (VVA).
Vulvovaginal Atrophy (VVA) is a serious medical condition that affects over 32 million postmenopausal women in the US. Only 7% of those suffering are being treated due to limitations of currently available products. More than 3.5 million breast cancer survivors have no safe therapy available.
Many women attribute VVA menopause symptoms to an unavoidable natural aging process that they need to just “live with”. They are uncomfortable discussing these symptoms and are not active in seeking help.
Women must be postmenopausal or bilaterally oophorectomized (removal of both ovaries).
Requirements
- Female
- Healthy
- 45 - 60 years old
- BMI 18 - 34 kg/m2
- Non-smoker
Study visits
2 nights, 3 clinic visits